Your Pathways in Precision Medicine
Each department represents a core pillar of precision medicine—designed to help physicians transform complex biological insight into actionable, personalized care.
Multi-Omics
Harness the power of genomics, transcriptomics, proteomics, and metabolomics to uncover the biological mechanisms that drive disease.
By integrating multi-layered biological data, physicians gain deeper insight into individual disease risk, molecular pathways, and therapeutic response—enabling highly targeted, personalized treatment strategies.
Learn MoreSystems Biology
Move beyond isolated biomarkers and single-pathway thinking to understand disease as part of a dynamic and interconnected biological system.
Systems biology enables physicians to identify complex disease networks, predict disease progression, and implement preventive, precision-based interventions that address root causes rather than symptoms.
Learn MoreClinical Medicine
Translate scientific discovery into real-world patient care.
Through advanced clinical models, precision medicine integrates biomarker analysis, clinical data, and individualized treatment protocols to identify key disease drivers and deliver personalized therapeutic strategies across diverse patient populations.
Learn MorePrecision Medicine in Action
Watch this short feature to see how precision medicine is transforming clinical care moving from generalized treatment to data-driven, personalized healthcare that improves outcomes.
Precision Oncology
Department
The ABOPM Precision Oncology Department trains physicians to integrate tumor genomics, liquid biopsy, immunoprofiling, and targeted therapeutics into individualized treatment strategies — moving beyond population averages to treat each cancer as the unique disease it is.
Visit Department PageCancer care is moving from one protocol for everyone to a therapy built around each tumor's biology.
Precision Oncology sits at the core of ABOPM's mission because cancer is the clearest proof case for precision medicine itself: every tumor carries a distinct genomic signature, and treating it as generic disease rather than individual biology costs patients time, response, and survival.
By establishing a board-certified standard for interpreting tumor genomics, monitoring treatment response, and matching patients to targeted and immune therapies, ABOPM gives physicians a credentialed framework the field currently lacks — and positions the organization at the forefront of where oncology is headed.
Sets the Clinical Standard
Establishes a rigorous, board-certified benchmark for genomic-driven cancer care where none currently exists.
Anchors a $560B Field
Prepares physicians for the fastest-growing segment of precision medicine, where genomic-guided treatment is now standard of care.
Strengthens ABOPM's Credibility
Demonstrates the depth of ABOPM's multidisciplinary faculty and reinforces its standing with partners, grantors, and academic collaborators.
Comprehensive Genomic Profiling
Somatic mutation analysis, copy number alterations, gene fusions, and mutational signatures across all tumor types.
Liquid Biopsy & ctDNA Monitoring
Real-time treatment response monitoring, minimal residual disease detection, and early resistance identification.
Immune Microenvironment Analysis
TMB, MSI status, PD-L1 expression, and TIL infiltration to identify immunotherapy responders.
Resistance Mechanism Mapping
Identifying acquired resistance pathways and adapting therapeutic strategy before clinical progression.
Identify actionable somatic mutations, copy number alterations, and gene fusions across every tumor site.
Guide institutional precision cancer programs and complex genomic treatment decisions.
Use ctDNA analysis to detect minimal residual disease and adapt therapy in real time.
Identify which patients respond to checkpoint inhibitors vs. combination or alternative immune strategies.
Every tumor has a molecular story.
Are you trained to read it?
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Global Genomics Initiatives Expanding Precision Medicine
Discover how global genomics initiatives are expanding precision medicine through diverse population data, large-scale sequencing, disease risk prediction, rare disease research, and advances in perso... ...more
Population Precision
September 17, 2026•8 min read
Liquid Biopsy 2.0: Beyond Cancer Detection
Liquid Biopsy 2.0 is moving beyond cancer. Discover how circulating biomarkers, cell-free DNA, RNA, and extracellular vesicles could transform disease detection, monitoring, and the future of precisio... ...more
On the Frontier
September 10, 2026•8 min read
Implementing Precision Medicine in Primary Care
Explore how precision medicine is transforming primary care through genomics, biomarkers, pharmacogenomics, risk prediction, and clinical decision support helping clinicians personalize prevention, tr... ...more
Precision Medicine in Action
September 04, 2026•8 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.